Mail

Recent Posts

• Study suggests BMPER protein as treatment target in PAH
• I’ve discovered a new tool to avoid triggers: ‘glimmers’
• Combination therapy effective in PAH with heart disease risk factors
• Liquidia gets $50M more after first sale of Yutrepia to treat PH
• Phase 3 PAH trial of ralinepag fully enrolled, results expected in 2026